Company Profile

  1. You are here:    Home
  2. Search Databases
  3. Search Company Registry
  4. Company Profile

DarPharma Inc
Profile last edited on: 6/19/08      CAGE:       UEI:

Business Identifier: compounds for treating brain diseases and disorders
Year Founded
2001
First Award
2002
Latest Award
2006
Program Status
Inactive (Acquired)
Popularity Index

Edit Company Profile

Is this YOUR Company?
Ensure accuracy and completeness of YOUR Company Profile by completing the brief Survey Instrument attached
Do you know about this Awardees?
Let us encourage you to provide any data which would enhance the completeness of this firm's profile.
  Explanation Edit

Location Information

215 Cloister Court
Chapel Hill, NC 27514
   (919) 403-4348
   info@darpharma.com
   www.darpharma.com
Location: Single
Congr. District: 04
County: Orange

Public Profile

In November of 2005, DarPharma Inc was acquired by BioValve. DarPharma was founded on discoveries patented by Professors Richard Mailman of the University of North Carolina at Chapel Hill and David Nichols of Purdue University. The company has an exclusive license agreement for families of drugs in a portfolio of five issued patents and several pending applications. Dr. Laurene Wang-Smith, formerly of Triangle Pharmaceuticals and GlaxoWellcome, directs the drug development efforts of the company

Extent of SBIR involvement

User Avatar
Phase I Awards
1
Phase II Awards
1
Conversion Rate
100.00%
Phase I Dollars
$99,943
Phase II Dollars
$2,348,722
Total Awarded
$2,448,665

Synopsis: Awardee Business Condition

Employee Range
10-14
Revenue Range
1M-1.5M
VC funded?
Yes
Public/Private
Privately Held
Stock Info
----
IP Holdings
1-4

Awards Distribution by Agency

Most Recent SBIR Projects
Year Phase Agency Total Amount
2006 2 NIH $2,448,665
Project Title: Novel Pharmacotherapy for Parkinson's Disease

Key People / Management

  Prabhavathi B Fernandes -- President

  Michael B Jacobson

  Laurene Wang-Smith

Company News

There are no news available.